IRLAB Therapeutics AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Jan-Fredrik Wilhelm Backman, was filed 17 Jul 2026.
IRLAB Therapeutics AB: what insiders have been doing
Every trade that managers of IRLAB Therapeutics AB disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. Between 3 November 2025 and 3 November 2026, 15 insiders published 19 filings.
The flow runs one way only: 3 insiders bought (5 purchases totalling €102k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 3 board members. Biggest ticket of the year: €45k, bought by Joakim Tedroff and made public on 28 November 2025 (0.21% of market cap).
The most recent open-market purchase was published on 17 July 2026, 114 days ago. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades.
Compared with its exchange (1,032 companies, median 9 filings), a count of 19 filings is above the norm. Over the whole record (from 2017), the tally stands at 27 purchases and 9 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Who traded when
BuySaleFinancial data
as of FY 2025FY ended December 2025 · cache
- 1,000,000 shares@ SEK 0.178100.0% of flowTeckningsoptionFI:csv-ce61a947aedc3f4ed8d0Canonical exit: 15 Oct 2026 (T+90)
- 10,500 shares@ US$0.144.7% of flowAktieISIN SE0012675361FI:csv-35717e7a0931ae76cb93Canonical exit: 6 Oct 2026 (T+90)
- 200,000 shares@ US$0.1595.3% of flowAktieISIN SE0012675361FI:csv-844ff39e4cac1d0d42e2Canonical exit: 5 Oct 2026 (T+90)
- 97,369 shares@ SEK 1.200.042% mcap32.5% of flowAktieISIN SE0012675361FI:csv-75e3ad9e602aca825661
- 202,631 shares@ SEK 1.2067.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-22bfd22bba1034efbae4
- 67,618 shares@ SEK 1.200.029% mcap32.5% of flowAktieISIN SE0012675361FI:csv-6afbe8f6601ec1188497
- 140,716 shares@ SEK 1.2067.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-2c830c6519ddb45ef9a1
- 54,094 shares@ SEK 1.200.023% mcap32.5% of flowAktieISIN SE0012675361FI:csv-38d280ab09db282c0366
- 112,573 shares@ SEK 1.2067.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-a2fc0dc8407569dc4fe0
- 52,333 shares@ SEK 1.2027.9% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-c6e5dad78154c1e4dd97
- 31,000 shares@ SEK 1.2016.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-d7e8a96b42391e08e898
- 183,858 shares@ SEK 1.2073.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-df7cf2154fe892975198
- 4,016,742 shares@ SEK 1.2062.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-fd654d5a64a63337a524
- 250,000 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-644fe006c9298328bad7
- 66,142 shares@ SEK 1.2026.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-7f4c847a7582f9e90c96
- 427,416 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-bc0ef732bc436e9724fa
- 555,842 shares@ SEK 1.208.6% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:csv-042e9dab302a546e5d34
- 250,000 shares@ SEK 2.000.21% mcap6.5% of flowAktieISIN SE0012675361FI:A003U250-1Canonical exit: 26 Feb 2026 (T+90)
- 70,000 shares@ SEK 2.000.058% mcap1.8% of flowAktieISIN SE0012675361FI:A003U002-1Canonical exit: 18 Feb 2026 (T+90)
- 36,000 shares@ SEK 3.5055.7% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003R127-1
- 357,327 shares@ SEK 3.5015.9% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003Q791-1
- 116,196 shares@ SEK 3.505.2% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003Q787-1
- 7,500 shares@ SEK 43.70AktieISIN SE0012675361FI:csv-b32178c5aa7ec9cbc4f7
- 3,130 shares@ SEK 27.0035.6% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-6353ff7587cee2741b09
- 5,666 shares@ SEK 27.0064.4% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-6a83f314eb05720d3430
25 of 71 declarations
About IRLAB Therapeutics AB
IRLAB Therapeutics AB is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
